Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons

The role of D2-autoreceptors in regulating dopamine neuron activity and transmission

(2014) C.P. Ford   NEUROSCIENCE

Therapeutic prospects for Parkinson disease

(2013) C. Warren Olanow et al.   ANNALS OF NEUROLOGY

Parkinson’s disease is associated with altered expression of CaV1 channels and calcium-binding proteins

(2013) Michael J. Hurley et al.   BRAIN

Increased excitability in serotonin neurons in the dorsal raphe nucleus in the 6-OHDA mouse model of Parkinson's disease

(2013) Alexander Prinz et al.   EXPERIMENTAL NEUROLOGY

Neuronal vulnerability, pathogenesis, and Parkinson's disease

(2013) David Sulzer et al.   MOVEMENT DISORDERS

Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD)

(2013)   MOVEMENT DISORDERS

Spontaneous Inhibitory Synaptic Currents Mediated by a G Protein-Coupled Receptor

(2013) Stephanie C. Gantz et al.   NEURON

Normalizing dopamine D2 receptor-mediated responses in D2 null mutant mice by virus-mediated receptor restoration: Comparing D2L and D2S

(2013) K.A. Neve et al.   NEUROSCIENCE

Physiological Phenotype and Vulnerability in Parkinson's Disease

(2013) D. J. Surmeier et al.   Cold Spring Harbor Perspectives in Medicine

Use of Calcium Channel Blockers and Parkinson’s Disease

(2012) Björn Pasternak et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Calcium, Bioenergetics, and Neuronal Vulnerability in Parkinson's Disease

(2012) D. James Surmeier et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Dual Control of Dopamine Synthesis and Release by Presynaptic and Postsynaptic Dopamine D2 Receptors

(2012) A. Anzalone et al.   JOURNAL OF NEUROSCIENCE

Are you or aren’t you? Challenges associated with physiologically identifying dopamine neurons

(2012) Mark A. Ungless et al.   TRENDS IN NEUROSCIENCES

Dihydropyridine calcium channel blockers and the progression of parkinsonism

(2011) Connie Marras et al.   ANNALS OF NEUROLOGY

Parkinson's Disease: Genetics and Pathogenesis

(2011) Joshua M. Shulman et al.   Annual Review of Pathology-Mechanisms of Disease

Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs

(2011) Russell C. Callaghan et al.   DRUG AND ALCOHOL DEPENDENCE

Milestones in PD genetics

(2011) Thomas Gasser et al.   MOVEMENT DISORDERS

Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors

(2011) Estefanía P Bello et al.   NATURE NEUROSCIENCE

Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates

(2011) Timothy J. Collier et al.   NATURE REVIEWS NEUROSCIENCE

The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease

(2011) E. Ilijic et al.   NEUROBIOLOGY OF DISEASE

Projection-Specific Modulation of Dopamine Neuron Synapses by Aversive and Rewarding Stimuli

(2011) Stephan Lammel et al.   NEURON

Dopamine release in the basal ganglia

(2011) M.E. Rice et al.   NEUROSCIENCE

The Physiology, Signaling, and Pharmacology of Dopamine Receptors

(2011) J.-M. Beaulieu et al.   PHARMACOLOGICAL REVIEWS

How Modeling Can Reconcile Apparently Discrepant Experimental Results: The Case of Pacemaking in Dopaminergic Neurons

(2011) Guillaume Drion et al.   PLoS Computational Biology

Exploring the function and pharmacotherapeutic potential ­of voltage-gated Ca2+channels with gene-knockout models

(2010) Jörg Striessnig et al.   Channels

Pacemaking in Dopaminergic Ventral Tegmental Area Neurons: Depolarizing Drive from Background and Voltage-Dependent Sodium Conductances

(2010) Z. M. Khaliq et al.   JOURNAL OF NEUROSCIENCE

Control of Extracellular Dopamine at Dendrite and Axon Terminals

(2010) C. P. Ford et al.   JOURNAL OF NEUROSCIENCE

Tolerability of isradipine in early Parkinson's disease: A pilot dose escalation study

(2010) Tanya Simuni et al.   MOVEMENT DISORDERS

Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1

(2010) Jaime N. Guzman et al.   NATURE

Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease

(2010) Christian Lüscher et al.   NATURE REVIEWS NEUROSCIENCE

Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases

(2009) Xiao-xia Dong et al.   ACTA PHARMACOLOGICA SINICA

Neuronal Calcium Sensor-1 (Ncs1p) Is Up-regulated by Calcineurin to Promote Ca2+Tolerance in Fission Yeast

(2009) Nobuko Hamasaki-Katagiri et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Robust Pacemaking in Substantia Nigra Dopaminergic Neurons

(2009) J. N. Guzman et al.   JOURNAL OF NEUROSCIENCE

NCS-1 in the Dentate Gyrus Promotes Exploration, Synaptic Plasticity, and Rapid Acquisition of Spatial Memory

(2009) Bechara J. Saab et al.   NEURON

R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice

(2009) Y. Tong et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Dopamine agonists in Parkinson’s disease

(2008) Mitsutoshi Yamamoto et al.   Expert Review of Neurotherapeutics

Cell type-specific subunit composition of G protein-gated potassium channels in the cerebellum

(2008) Carolina Aguado et al.   JOURNAL OF NEUROCHEMISTRY

Expression and 1,4-Dihydropyridine-Binding Properties of Brain L-Type Calcium Channel Isoforms

(2008) M. J. Sinnegger-Brauns et al.   MOLECULAR PHARMACOLOGY

Metabotropic Glutamate Receptor-Mediated LTD Involves Two Interacting Ca2+ Sensors, NCS-1 and PICK1

(2008) Jihoon Jo et al.   NEURON

Unique Properties of Mesoprefrontal Neurons within a Dual Mesocorticolimbic Dopamine System

(2008) Stephan Lammel et al.   NEURON